Aortic connexin43 is decreased during hypertension induced by inhibition of nitric oxide synthase

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 7, 1999, Pages 1615-1622

  Haefliger, Jacques Antoine ^a   Meda, Paolo ^b   Formenton, Andrea ^a   Wiesel, Philippe ^a   Zanchi, Anne ^a   Brunner, Hans R ^a   Nicod, Pascal ^a   Hayoz, Daniel ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Aorta; Connexin; Elasticity; Heart; Hypertension; Nitric oxide

Indexed keywords

CONNEXIN 43; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ARTERY COMPLIANCE; ARTERY TONE; ARTICLE; CELL COMMUNICATION; ENZYME INHIBITION; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RAT; SMOOTH MUSCLE CONTRACTILITY;

EID: 0033067097     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.7.1615     Document Type: Article

References (50)

1. Musil LS, Goodenough DA. Gap junctional intercellular communication and the regulation of connexin expression and function. Curr Opin Cell Biol. 1990;2:875-880.
2. Spray DC, Burt JM. Structure-activity relations of cardiac gap-junction channel. Am J Physiol. 1990;258:C195-C205.
3. 1-adrenergic contractility in isolated vascular tissue by heptanol: a functional demonstration of the potential importance of intercellular communication to vascular response generation. Life Sci. 1995;56:709-721.
4. Segal SS. Cell-to-cell communication coordinates blood flow control. Hypertension. 1994;23:1113-1120.
5. Larson DM, Haudenschild CC, Beyer EC. Gap junction messenger RNA expression by vascular wall cells. Circ Res. 1990;66:1074-1080.
6. Moore LK, Beyer EC, Burt JM. Characterization of gap junction channels in A7r5 vascular smooth muscle cells. Am J Physiol. 1991;260: C975-C981.
7. Christ GJ, Moreno AP, Parker ME, Gondre CM, Valcic M, Melman A, Spray DC. Intercellular communication through gap junctions: a potential role in pharmacomechanical coupling and syncytial tissue contraction in vascular smooth muscle isolated from the human corpus cavernosum. Life Sci. 1991;49: PL195-PL200.
8. Christ GJ, Brink PR, Zhao W, Moss J, Gondré CM, Roy C, Spray DC. Gap junctions modulate tissue contractility and alpha adrenergic agonist efficacy in isolated rat aorta. J Pharmacol Exp Ther. 1993;266: 1054-1065.
9. Christ GJ, Spray DC, El-Sabban M, Moore LK, Brink PR. Gap junction in vascular tissues: evaluating the role of the intercellular communication in the modulation of vasomotor tone. Circ Res. 1996;79:631-646.
10. Severs NJ. Pathophysiology of gap junctions in heart disease. J Cardiovasc Electrophysiol. 1994;5:462-475.
11. Haefliger J-A, Castillo E, Waeber G, Bergonzelli GE, Aubert J-F, Sutter E, Nicod P, Waeber B, Meda P. Hypertension increases connexin43 in a tissue-specific manner. Circulation. 1997;95:1007-1014.
12. Haefliger J-A, Castillo E, Waeber G, Aubert J-F, Nicod P, Waeber B, Mcda P. Hypertension differentially affects the expression of the gap junetional protein connexin43 in cardiac myocytes and aortic smooth muscle cells. Adv Exp Med Biol. 1997;432:71-82.
13. Watts SW, Webb RC. Vascular gap junctional communication is increased in mineralocorticoid-salt hypertension. Hypertension. 1996;28: 888-893.
14. Mulvany MJ. A reduced elastic modulus of vascular wall components in hypertension. Hypertension. 1992;20:7-9.
15. Zanchi A, Wiesel P, Aubert J-F, Brunner HR, Hayoz D. Time course changes of the mechanical properties of the carotid artery in renal hypertensive rats. Hypertension. 1997;29:1199-1203.
16. Ribeiro MO, Amures E, de Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension. 1992;20:298-303.
17. Numaguchi K, Egashira K, Takemoto M, Kadokami T, Shimokawa H, Sueishi K, Takeshita A. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension. 1995; 26:957-962.
18. Kato H, Hou J, Chobanian AV, Brecher P. Effects of angiotensin II infusion and inhibition of nitric oxide synthase on the rat aorta. Hypertension. 1996;28:153-158.
19. Arnal JF, el Amrani AI, Chatellier G, Ménard J, Michel JB. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension. 1993;22:380-387.
20. Delacrétaz E, Zanchi A, Nussberger J, Hayoz D, Aubert JF, Brunner HR, Waeber B. Chronic nitric oxide synthase inhibition and carotid artery distensibility in renal hypertensive rats. Hvpertension. 1995;26:332-336.
21. Delacrétaz E, Hayoz D, Osterheld MC, Genton CY, Brunner HR, Waeber B. Long-term nitric oxide synthase inhibition and distensibility of carotid artery in intact rats. Hypertension. 1994;23(pt 2):967-970.
22. Rees DD, Palmer RJM, Schultz R, Hodson HF, Moneada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990;101:746-752.
23. Devlin AM, Brosnan MJ, Graham D, Morton JJ, McPhaden AR, McIntyre M, Hamilton CA, Reid JL, Dominiczak AF. Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo. Am J Physiol. 1998:274:H52-H59.
24. Fluckiger JP, Gremaud G, Waeber B, Kulik A, Ichino A, Nussberger J, Brunner HR. Measurement of sympathetic nerve activity in the unanesthetized rat. J Appl Physiol. 1989;167:250-255.
25. Beyer EC, Paul DL, Goodenough DA. Connexin43: a protein from rat heart homologous to a gap junction protein from liver. J Cell Biol. 1987;105:2621-2629.
26. Fort P, Marty L, Piechaczyck M, el Sabrouty S, Dani C, Jeanteur P, Blanchard JM. Various rat adult tissues express only one major mRNA species from glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 1985;13:1431-1442.
27. Gustafson TA, Markham BE, Morkin E. Effects of thyroid hormone on α-actin and myosin heavy chain gene expression in cardiac and skeletal muscles of the rat: measurements of mRNA content using synthetic oligonucleotide probes. Circ Res. 1986;59:194-201.
28. Porret CA, Stergiopulos N, Hayoz D, Brunner HR, Meister JJ. Simultaneous ipsilateral and contralateral measurements of vasomotion in conduit arteries of human upper limbs. Am J Physiol. 1995;269: H1852-H1858.
29. Hayoz D, Drexler H, Münzel T, Hornig B, Zeiher AM, Just H, Brunner HR, Zelis R. Flow mediated arterial dilation is abnormal in congestive heart failure. Circulation. 1993;87:92-96.
30. Langerwouters GJ, Wesseling KH, Godehard WJA. The static elastic properties of 45 human thoracic and 20 abdominal aortas in vitro and the parameters of a new model. J Biomech. 1984;17:425-435,
31. Weber R, Stergiopulos N, Brunner HR, Hayoz D. Contributions of vascular tone and structure to elastic properties of a medium size artery. Hypertension. 1996;27:816-822.
32. O'Rourke MF, Brunner HR. Introduction to arterial compliance and function. J Hypertens. 1992;10:3-5.
33. Levy BI, Safar ME. Remodelling of the vascular system in response to hypertension and drug therapy. Clin Exp Pharmacol Physiol Suppl. 1992; 19:33-37.
34. Wiesel P, Hayoz D, Kuhn L, Nussberger J. Superoxide anion production and intracellular iron handling in the aorta of short and very long term renovascular hypertensive rats. Circulation. 1997;96(suppl I):I-539. Abstract.
35. Smulyan H, Vardan S, Griffiths A, Gribbin B. Forearm arterial distensibility in systolic hypertension. JAMA. 1984;3:387-393.
36. Kung CF, Moreau P, Takase H, Luscher TF. L-NAME hypertension alters endothelial and smooth muscle function in rat aorta: prevention by trandolapril and verapamil. Hypertension. 1995;26:744-751.
37. Boutouyrie P, Bézie Y, Lacolley P, Challande P, Chamiot-Clerc P, Benetos A, Renaud de la Faverie J-F, Safar M, Laurent S. In vivo/in vitro comparison of rat abdominal aorta wall viscosity. Arterioscler Thromb Vasc Biol. 1997;17:1346-1355.
38. Segal SS, Duling BR. Flow control among microvessels coordinated by intercellular conduction. Science. 1986;234:868-870.
39. Musil LS, Cunningham BA, Edelman GM, Goodenough DA. Differential phosphorylation of the gap junction protein connexin43 in junctional communication-competent and -deficient cell lines. J Cell Biol. 1990; 111:2077-2088.
40. Musil LS, Goodenough DA. Biochemical analysis of connexin43 intracellular transport, phosphorylation and assembly into gap junctional plaques. J Cell Biol. 1991;115:1357-1374.
41. Warn-Cramer BJ, Cottrell GT, Lau AF. Regulation of connexin-43 gap junctional intercellular communication by mitogen-activated protein kinase. J Biol Chem. 1998;10:9188-9196.
42. Dubey RK, Jackson EK, Lüscher TF. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell: role of cyclic-nucleotides and angiotensin 1 receptors. J Clin Invest. 1995;96:141-149.
43. Pollman MJ, Yamada T, Horiuchi M, Gibbons GH. Vasoactive substances regulate vascular smooth muscle cell apoptosis: countervailing influences of nitric oxide and angiotensin II. Circ Res. 1996;79:748-756.
44. Blackburn JP, Peters NS, Yeh H-I, Rothery S, Green CR, Severs NJ. Upregulation of Cx43 gap junctions during early stages of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15: 1219-1228.
45. Bishopric NH, Simpson PC, Ordahl CP. Induction of the skeletal α-actin in alpha1-adrenoceptor-mediated hypertrophy in rat cardiac myocytes. J Clin Invest. 1987;80:1194-1199.
46. Schwartz K, de la Bastie D, Bouveret P, Oliviéro P. Alonso S, Buckingham M. α-Skeletal muscle actin mRNA's accumulate in hypertrophied adult rat hearts. Circ Res. 1986;59:551-555.
47. 1 adrenoceptor signalling in DOCA-salt hypertension in rats. Cordiovasc Res. 1992;26:878-885.
48. Wiesel P, Mazzolai L, Nussberger J, Pedrazzini T. Two-kidney, one clip and one-kidney, one clip hypertension in mice. Hypertension. 1997;29: 1025-1030.
49. Bastide B, Neyses L, Ganten D, Paul M, Willecke K, Traub O. Gap junction protein connexin40 is preferentially expressed in vascular endothelium and conductive bundles of rat and is increased under hypertensive conditions. Circ Res. 1993;73:1138-1149.
50. Kanter HL, Laing JG, Beyer EC, Green KG, Saffitz JE. Multiple connexins colocalize in canine ventricular myocyte gap junctions. Circ Res. 1993;73:344-350.